Browse EX-10 agreements

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 9, 2026 (the “Execution Date”), is entered into by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and the accredited investor named on the signature page to this Agreement (the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement, dated as of the date hereof, by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

A. The Company and the Buyer have entered into the Purchase Agreement, pursuant to which the Company may issue to the Buyer, from time to time, up to the lesser of (a) $40,000,000 and (b) 19.99% of the Company’s outstanding common stock, par value $0.0001 per share (the “Common Stock”) as of the date of this Agreement, unless shareholder approval is obtained to issue more than such 19.99%; and

…

COMMON STOCK PURCHASE AGREEMENT

This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of June 9, 2026 (this “Agreement”), by and among C/M Capital Partners, LP, a [ ] limited liability company (the “Investor”), and Jaguar Health, Inc., a Delaware corporation (the “Company”).

RECITALS

WHEREAS, the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to the lesser of (a) $40,000,000 and (b) 19.99% of the Company’s outstanding shares of Common Stock as of the date of this Agreement, unless (i) stockholder approval is obtained to issue more than such 19.99% (“Stockholder Approval”) or (ii) the price of applicable sales of Common Stock to the Investor under this Agreement equals or exceeds the lower of (A) the official Closing Sale Price on the Eligible Market on which the Company’s Common Stock is then listed or quoted for trading immediately precedi

…

AMENDED AND RESTATED COMPENSATION AGREEMENT

This AMENDED AND RESTATED COMPENSATION AGREEMENT (this “Agreement”) is entered into as of June 5, 2026 (the “Effective Date”), by and between Eightco Holdings Inc., a Texas corporation (the “Company”), and Kevin O’Donnell (the “Executive”), and amends and restates in its entirety that certain Compensation Agreement dated September 8, 2025, by and between the Company and Executive (the “Original Agreement”).

 

RECITALS

WHEREAS, the Company and Executive entered into the Original Agreement, pursuant to which Executive has been serving as the Company’s Chief Executive Officer; and

 

WHEREAS, the Company and Executive desire to amend and restate the Original Agreement in its entirety to, among other things, extend the term of Executive’s employment and modify certain compensation and termination provisions, on the terms and conditions set forth herein; and

…

Alaska Silver Corp.: Exhibit 10.1 - Filed by newsfilecorp.com

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

THE PARTIES, BY THEIR SIGNATURES BELOW, HEREBY REPRESENT THAT THEY HAVE READ AND UNDERSTAND THE CONTENTS OF THIS AGREEMENT, THAT NO REPRESENTATIONS OTHER THAN THOSE CONTAINED HEREIN HAVE BEEN MADE TO THEM TO INDUCE OR INFLUENCE THEIR EXECUTION OF THIS AGREEMENT, AND THAT THEY EXECUTE THIS AGREEMENT KNOWINGLY AND VOLUNTARILY.

ALASKA SILVER

Per: /s/ David Smallhouse                                            

 David Smallhouse

 Board of Director             

Date: June 10, 2026                                                         

 

 

 

 /s/ Aaron Schutt

Witness

 

Aaron Schutt

Date: May 21, 2026

Date: May 29, 2026

---

johncfortsonofferletter

P a g e 1 | 4 May 29, 2026 John Fortson johnfortson@rocketmail.com Dear John, On behalf of Dentsply Sirona, I am pleased to offer you the role of Executive Vice President & Chief Financial Officer. In this role, you will report to Dan Scavilla, our Chief Executive Officer. Your anticipated start date is on or about June 29, 2026, based on meeting your current employer notice period commitments. We feel strongly that you are the right person for this job. You have great experience and will fit in well with our executive team. The material terms covering compensation and benefits are listed below: Compensation: Base Salary: Your annual salary will be $780,000 payable bi-weekly at a rate of $30,000, in accordance required by law. Annual Incentive: You will be eligible to participate in the Dentsply Sirona Annual Incentive Plan (AIP) according to its terms, as amended from time to time at the sole discretion of the Company. The plan is designed to encourage achievement of important business objectives. Your target annual incentive payout under the AIP will be 85%

…

CONFIDENTIAL

 

Supply Agreement

 

Between the undersigned

 

Techforce Robotics, Inc.

a corporation organized and existing under the laws of the State of Delaware, United States,

having its principal office at 13501 Main St, Los Angeles, CA 90061, United States

Hereinafter referred to as “Purchaser”

 

and

 

Jiun Jiang Enterprise Co., Ltd.

a company duly incorporated under the laws of the Republic of China (“R.O.C.”),

with its principal office at 16-25, San Yueh Rd., Houli Township,

Taichung City 421006,

Taiwan, R.O.C.

Hereinafter referred to as “Supplier”

 

Purchaser and Supplier hereinafter will be referred to individually as the “Party” or collectively as the “Parties.”

 

1

 

 

Contents

 

Section 1 - Definitions

3

 

 

Section 2 - Term

5

 

 

Section 3 - Order of Precedence

5

 

 

Section 4 - Scope of Work; Changes to the Product

6

 

 

Section 5 - Forecast; Order

7

 

 

Section 6 - E&O Inventory

8

 

 

Section 7 - Delivery

9

 

 

Section 8 - Price; Payment Term

10

…

Execution Copy

 

Personal Employment Agreement

This Personal Employment Agreement (this “Agreement”), is made as of June 7, 2026, by and between Duke Robotics Corp. a US Nevada State registered corporation, with offices at 10 Ha’Rimon St, Science and Industrial Park Mevo Carmel, Israel (the “Company”) and Yiftach Kleinman (ID No. 027788751) (the “Executive”) of Yefe Nof St 23, Ashkelon, Israel.

 

WHEREAS,

the Company wishes to employ the Executive; while the Executive’s actual employment shall be with the Company’s Israeli subsidiary, Duke Airborne Systems Ltd., registration number 515051282, and the Executive wishes to enter into such employment, subject to and in accordance with the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, it has accordingly been warranted, provided and agreed by the parties as follows:

 

Recitals, Headings and Interpretation

 

1.1

The recitals to this Agreement constitute an integral part hereof.

 

1.2

…

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 11, 2026, by and among Spark I Acquisition Corporation, a Cayman Islands exempted company (the “Company”), ZincFive, Inc., a Delaware corporation (the “Target”), and the purchasers identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).

…

STOCKHOLDER VOTING AND SUPPORT AGREEMENT

 

This Stockholder Voting and Support Agreement (this “Agreement”) is dated as of [●], 2026, by and among Spark I Acquisition Corporation, a Cayman Islands exempted company limited by shares (which shall transfer by way of continuation and domesticate as a Delaware corporation) (“Acquiror”), the Person set forth on the signature page hereto (the “Company Stockholder”), and ZincFive, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

 

RECITALS

…

EXHIBIT C

 

SPONSOR AGREEMENT

 

This SPONSOR AGREEMENT (this “Agreement”) is dated as of June 11, 2026 (the “Effective Date”), by and among Spark I Acquisition Corporation, a Cayman Islands exempted company (which shall domesticate as a Delaware corporation prior to the Closing) (“SPAC”), SLG SPAC Fund LLC, a Delaware limited liability company (the “Sponsor”), ZincFive, Inc., a Delaware corporation (the “Company”), certain shareholders of SPAC set forth on Schedule I hereto (together with the Sponsor, collectively, the “Insiders” and each, an “Insider”), solely for purposes of Section 1.16 hereto, the individual set forth on Schedule II hereto (the “Non-Shareholder Insider”). Capitalized terms used but not defined in this Agreement shall have the meanings given to those same terms in the Merger Agreement (as defined below).

…

---

Exhibit 10.1

SECOND AMENDMENT TO

AMENDED AND RESTATED CREDIT AGREEMENT

This SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is executed as of June 10, 2026 to be effective for all purposes as of April 1, 2026, among PRAIRIE OPERATING CO., a Delaware corporation (the “Borrower”), each other Credit Party party hereto, each of the Lenders party hereto and CITIBANK, N.A., as administrative agent (in such capacity, together with its successors in such capacity, the “Administrative Agent”).

 

RECITALS

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of June 10, 2026, between Atossa Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

1.1

…